The DOI matches its Crossref record.
Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance
Abstract
We measured serum antibodies to botulinum toxin (ABT) in 96 patients with focal dystonia who had been treated with type A botulinum toxin. The frequency of detectable ABT was 3% (three patients). Patients with ABT had received more than 50 ng of botulinum toxin, and the shortest time between two injections was significantly less than in patients without ABT. The clinical evolution of the three patients was heterogeneous: one had decreased effectiveness with repeated injections, another had persistent improvement, and the third never responded to toxin injections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
Brin, M. F., Lew, M. F., Adler, C. H., Comella, C. L., Factor, S. A., Jankovic, J., O’Brien, C., Murray, J. J., Wallace, J. D., Willmer–Hulme, A., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1431 · Cited by 437
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
Graham, H. K., Aoki, K. R., Autti-Rämö, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., et al. (2000) · Gait & Posture · doi:10.1016/s0966-6362(99)00054-5 · Cited by 399
European consensus table on the use of botulinum toxin type A in adult spasticity
Wissel, J., Ward, A., Erztgaard, P., Bensmail, D., Hecht, M., Lejeune, T., & Schnider, P. (2009) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0303 · Cited by 372
Pharmacology of botulinum toxin
Huang, W., Foster, J. A., & Rogachefsky, A. S. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.105567 · Cited by 349
Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences
Göschel, H., Wohlfarth, K., Frevert, J., Dengler, R., & Bigalke, H. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6580 · Cited by 315
Metadata
- Authors
- Zuber, M., Sebald, M., Bathien, N., de Recondo, J., & Rondot, P.
- Venue
- Neurology
- Published
- 1993-09
- Volume
- 43
- Issue
- 9
- Pages
- 1715-1715
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2061202434
- Cited by
- 195
- References
- 0
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance. https://app.cochat.ai/papers/10.1212/wnl.43.9.1715
- The paper
- Zuber, M., Sebald, M., Bathien, N., de Recondo, J., & Rondot, P. (1993). Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance. Neurology. https://doi.org/10.1212/wnl.43.9.1715
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.